drugset / Trial / NCT02757495

Can Caudal Dexmedetomidine Prevents Sevoflurane Induced Emergence Agitation in Children

NCT02757495 ↗

Phase 4 Completed 48 enrolled Suez Canal University
RandomizedParallel-groupDouble-blindTreatment

Summary

Emergence agitation (EA) is common phenomenon in pediatric patients undergoing general anesthesia by inhalation agents. The incidence of EA was reported to range from 18% to 80%. Sevoflurane now is the inhalational anesthetic agent of choice for pediatrics, Different strategies have been suggested to decrease the incidence and severity of EA. No gold standard technique for treating EA after sevoflurane anesthesia is currently available. The main question is can caudal dexmedetomidine be used for this purpose?

Timeline

Start
2016-04
Primary completion
2017-04
Completion
2017-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Dexmedetomidine Other / unclassified 2 ug/kg Other

Indications

No indication recorded.